Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Europharma Secures Rights to Kinospherine; Signs Agreement with VitaPlant - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Europharma Secures Rights to Kinospherine; Signs Agreement with VitaPlant

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Europharma, Green Bay, WI, has secured the North American rights to Kinospherine, a fat blocker. This patented complex of ingredients has been clinically shown to help prevent the absorption of dietary fats in the body, while maintaining healthy digestion. According to the company, Kinospherine blocks 21 grams of fat per day and is three and a half times more effective than chitosan. It has a high lipid absorption capacity, which prevents lipase action by blocking the fatty acids.

In other developments, Europharma has entered into a joint venture with VitaPlant, a Swiss research institute that studies phytomedicinal products. Europharma is currently funding six new research projects with VitaPlant in the development of new plant-based medicines. These new phytomedicinal products will be commercially available worldwide in 12 to 18 months.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics